Micropep Technologies
Micropep Technologies was incorporated in 2016 to build a unique discovery engine to rapidly identify plant bioactive peptides based on a natural, transient and localized regulation mechanism discovered by the company's scientific team. The solutions developed by Micropep unleash the natural potential of plants to help farmers better manage abiotic and biotic stresses, control weed growth and ultimately increase crop yields while preserving the environment.
Sector
Industrial Biotech
Strategies
Industrial Biotech
Status
Live
Website
www.micro-pep.com
Related News
Micropep and Corteva announce multi-year research collaboration to advance sustainable biocontrol solutions
Micropep raises $29m in Series B funding and unveils Krisalix, its proprietary discovery platform
FMC Corporation and Micropep Technologies announce strategic collaboration to co-develop bioherbicide solutions
Micropep, ag-biotech innovator, raises €8.75 million from global syndicate to bring ground-breaking and cost-effective alternatives to conventional crop protection products to market
Micropep Raises EUR 8.5M (USD 10M) in oversubscribed Series A Financing to develop innovative small peptide solutions for agriculture
SofinnovaCapital
The Sofinnova Capital Strategy is our flagship fund, investing as founding or lead investor in early-stage biopharma and medtech start-ups developing groundbreaking therapeutic technologies.
SofinnovaMD Start
The Sofinnova MD Start Strategy is our in-house medtech accelerator focused on creating and launching early-stage medtech companies through hands-on company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy invests in growth-stage biotech and medtech companies that have clinically validated their technologies and are preparing for commercialization.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy invests in early-stage sustainable companies across the agriculture, chemicals, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy makes early-stage investments in leading Italian science for the benefit of patients around the world.
SofinnovaDigital Medicine
Our Digital Medicine Strategy backs early-stage techbio and healthtech start-ups at the intersection of biology, data, and computation.
SofinnovaBiovelocita
The Sofinnova Biovelocita Strategy is our biotech accelerator, partnering with leading research organizations to create and build European biotech start-ups.